1990年 福岡大学大学院医学研究科修了 医学博士
1990年 脳神経外科専門医 日本脳神経外科学会認定
1993年 米国テキサス州立大学 M.D. Anderson 癌センター 脳神経外科
1995年 福岡大学病院脳神経外科 講師
2002年 福岡大学医学部脳神経外科 助教授
2005年 高尾野病院 副院長 （鹿児島県出水市）
2006年 水俣総合医療センター 脳神経センター非常勤医 兼任
2007年 さくら通りクリニック 院長
専門分野
頭痛治療
脳腫瘍
representative publications
- Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo /
Yamamoto, M., Sawaya,R., Mohanam, S., Loskutoff, D.J., Bruner, J.M., Rao, V.H., Oka, K., Tomonaga, M., Nicolson, G.L., Rao,J.S. - Cancer Res. (1994, 54: 3329-3332)
- Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo /
Yamamoto M., Sawaya, R., Mohanam, S., Bindyl, A.K., Bruner, J.M. Oka, K., Rao, V.H., Tomonaga, M., Nicolson, G.L., Rao,J.S. - Cancer Res.(1994, 54: 3656-3661)
- Expression and localization of urokinase-type plasminogen activator receptor in human gliomas /
Yamamoto, M., Sawaya, R., Mohanam, S., Rao, V.H., Bruner, J.M., Nicolson, G.L., Rao, J.S. - Cancer Res.(1994, 54: 5016-5020)
- Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression /
Yamamoto, M., Sawaya, R., Mohanam, S. Bruner, J.M., Nicolson, G.L., Ohshima, K., Rao,J.S. - J. Neuro-Oncology (1994, 22: 139-152)
- Plasminogen activator inhibitor-1 in brain tumors: Relation to malignancy and necrosis /
Sawaya, S., Yamamoto, M., Ramo, O.J., Shi, M.L., Rao, J.S. - Neurosurgery (1995, 36(2): 375-381)
- Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro /
Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G.N., Seiki, M., Sato, H., Gokaslan, Z.L., Liotta, L.A., Rao, J.S. - Cancer Res. (1996, 56: 384-392)
- Increased expression of low density lipoprotein receptor-related protein / a2-macroglobulin receptor in human malignant astrocytomas /
Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H., Tomonaga, M. - Cancer Res.(1997, 57: 2799-2805)
- Fibrinolytic system in human brain tumors. In: Advances in Neuro-Oncology II (Kornblith, Paul L., Ed.) Futura Publishing Company, Inc., Armonk, NY, pp 49-68, 1997
Rao, JS., Yamamoto, M., Bindal, AK., Shi, WM., Wu, SZ., and Sawaya, R.
- Giant cell tumor of the sphenoid bone: Long-term follow-up of two cases after chemotherapy /
Yamamoto, M., Fukushima, T., Sakamoto, S., Tomonaga, M. - Surg. Neurol. (1998, 49: 547-552)
- Treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) / Fukushima,T., Yamamoto, M., Ikeda, K., Tsugu, H., Kimura, H., Soma, G-I., Tomonaga, M. - Anticancer Research (1998, 18: 3965-3970)
- Correlation of the expression of nuclear factor-kB, tumor necrosis factor receptor type 1 (TNFR1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2)/
Yamamoto, M., Fukushima, T., Hayashi, S., Ikeda, K., Tsugu, H., Kimura, H., Soma, G-I., Tomonaga, M.-Anticancer Res. (2000, 20:611-618)
- Clinical Significance of the Expression of Endothelial-Monocyte Activating Polypeptide II (EMAPII) in the Treatment of Glioblastoma with Recombinant Mutant Human Tumor Necrosis Factor-alpha (TNF-SAM2) /
Yamamoto, M., FUKUSHIMA, F., UENO, Y., HAYASHI, S., KIMURA, H., SOMA, G., TOMONAGA, M.-Anticancer Res. (2000, 20,4081-4086)
- Expression of nuclear factor-kB, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas/
Hayashi S., Yamamoto, M., Ueno, U., Ikeda, K., Ohshima, K., Soma G-I., Fukushima, T.- Neurologia Medico-Chirurgica (Tokyo) (2001, 41:185-193)
脳血管障害
- Fructose 2, 6-bisphosphate on human erythrocyte /
Moriyasu, M., Yamamoto, M., Hamasaki, N. - J. Biochem. (Tokyo) (1988, 103 (6): 903-904)
- Fructose 2, 6-bisphosphate changes in rat brain during ischemia /
Yamamoto, M., Hamasaki, N., Maruta, Y., Tomonaga, M. - J. Neurochem. (1990, 54: 592-597)
- Circulation of red blood cells having high levels of 2, 3-Bisphosphoglycerate protects rat brain from ischemic metabolic changes during hemodilution /
Kimura, H., Hamasaki, N., Yamamoto, M., Tomonaga, M. - Stroke (1995, 26: 1431-1437)
- The clinical significance of cerebral veins in Moyamoya disease /
Kimura,H., Oka, K., Ikeda, K., Yamamoto, M., Tomonaga, M. - Clinical Neurology and Neurosurgery (1997, 99:S90-95)
- Red blood cell function and blood storage /
Hamasaki, N. and Yamamoto, M. -Vox Sanguinis, (2000, 79:191-197)
- Expression of nucelar factor-kB and TNF-a in mouse brain following experimental thermal ablation injury /
Nomoto, Y., Yamamoto, M., Fukushima, T., Kimura, H., Ohshima, K., Tomonaga, M. - Neurosurgery, (2001, 48: 158-166)
機能的脳疾患 その他
- Symptomatic Chiari malformation and associated pathophysiology in pediatric and adult patients without myelodysplasia /
Fukushima, T., Matsuda, T., Tsuchimochi, H., Yamamoto, M., Tsugu, H., Tomonaga, M., Mitsudome,A., Utsunomiya, H., Asakawa, K. - Neurologia Medico-Chirurgica (Tokyo) (1994, 34(11):739-743)
- Percutaneous flexible neuroendoscopic ventriculostomy in patients with shunt malfunction as an alternative procedure to shunt revision /
Yamamoto, M., Oka, K., Ikeda, K., Tomonaga, M. - Surgical Neurology (1994, 42: 218-223)
- Ventriculoscope-guided ventriculoperitoneal shunt and shunt revision - Technical note - /
Yamamoto, M., Oka, K., Nagasaka, S., Tomonaga,M. - Acta Neurochirugica (Wien) (1994, 129: 85-88)
- Flexible Neuroendoscopy for percutaneous treatment of intraventricular lesions in the absence of hydrocephalus / Yamamoto, M., Oka, K., Hachisuka, S., Miyake, E., Tomonaga, M. - Minim. Invas. Neurosurg. (1997, 40(4): 139-143)
Topへ
さくら通りクリニックHomePageへ
